Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CEPH -- Ignore unavailable to you. Want to Upgrade?

To: betty blank who wrote (816)	11/17/1998 12:10:00 AM
From: freelyhovering	Respond to of 998

Betty--I will check with friend again; but I thought he said it was a done deal. I will let you know. Myron

To: betty blank who wrote (816)	11/18/1998 6:08:00 PM
From: freelyhovering	Read Replies (1) \| Respond to of 998

Betty--Here is a response from my friend on CEPH"s drug. Myron cephelon has 2 drugs, and it is the other one that i know about, modafinil. i hear through sleep people in california that the drug should be coming out in january under the name provigil. from what i read on the webb, the myo drug has had problems demonstrating efficacy in the treatment of als. so a negative anouncement on myo could offset good news on modafinil. but it could be a real money maker if it starts getting prescibed for every adhd kid or sleepy adult.